Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study

The combination of cisplatin and 5-fluorouracil (5-FU) (PF) is the most popular regimen for treating metastatic nasopharyngeal carcinoma (NPC) but it is limited by severe stomatitis and chronic cisplatin-related toxicity. A novel approach including induction with mitomycin C, doxorubicin and cisplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, R L, Sheen, T S, Ko, J Y, Hsu, M M, Wang, C C, Ting, L L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363155/
https://www.ncbi.nlm.nih.gov/pubmed/10471046
http://dx.doi.org/10.1038/sj.bjc.6690627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363155/
https://www.ncbi.nlm.nih.gov/pubmed/10471046
http://dx.doi.org/10.1038/sj.bjc.6690627

Ejemplares similares